Vojtěch Bystrý, Ph.D.

Publications that are part of the Web of Science database, possibly also other publications chosen by authors.

2021

• Dykova, I; Zak, J; Reichard, M; Souckova, K; Slaby, O; Bystry, V; Blazek, R, 2021: Histopathology of laboratory-reared Nothobranchius fishes: Mycobacterial infections versus neoplastic lesions. JOURNAL OF FISH DISEASES 44(8), p. 1179 - 1190, doi: 10.1111/jfd.13378

2020

• Lobello, C; Tichy, B; Bystry, V; Radova, L; Filip, D; Mraz, M; Montes-Mojarro, IA; Prokoph, N; Larose, H; Liang, HC; Sharma, GG; Mologni, L; Belada, D; Kamaradova, K; Fend, F; Gambacorti-Passerini, C; Merkel, O; Turner, SD; Janikova, A; Pospisilova, S, 2020: STAT3 and TP53 mutations associate with poor prognosis in anaplastic large cell lymphoma. LEUKEMIA , doi: 10.1038/s41375-020-01093-1

2019

• Zaprazna, K; Reblova, K; Svobodova, V; Radova, L; Bystry, V; Baloun, J; Durechova, K; Tom, N; Loja, T; Buresova, M; Stranska, K; Oltova, A; Doubek, M; Atchison, ML; Trbusek, M; Malcikova, J; Pospisilova, S, 2019: Activation-induced deaminase and its splice variants associate with trisomy 12 in chronic lymphocytic leukemia. ANNALS OF HEMATOLOGY 98(2), p. 423 - 435, doi: 10.1007/s00277-018-3520-5
• Hynst, J; Plevova, K; Radova, L; Bystry, V; Pali, K; Pospisilova, S, 2019: Bioinformatic pipelines for whole transcriptome sequencing data exploitation in leukemia patients with complex structural variants. PEERJ 7, doi: 10.7717/peerj.7071
• Fazio, G; Massa, V; Grioni, A; Bystry, V; Rigamonti, S; Saitta, C; Galbiati, M; Rizzari, C; Consarino, C; Biondi, A; Selicorni, A; Cazzaniga, G, 2019: First evidence of a paediatric patient with Cornelia de Lange syndrome with acute lymphoblastic leukaemia. JOURNAL OF CLINICAL PATHOLOGY 72(8), p. 558 - 561, doi: 10.1136/jclinpath-2019-205707
• Knecht, H; Reigl, T; Kotrova, M; Appelt, F; Stewart, P; Bystry, V; Krejci, A; Grioni, A; Pal, K; Stranska, K; Plevova, K; Rijntjes, J; Songia, S; Svaton, M; Fronkova, E; Bartram, J; Scheijen, B; Herrmann, D; Garcia-Sanz, R; Hancock, J; Moppett, J; van Dongen, JJM; Cazzaniga, G; Davi, F; Groenen, PJTA; Hummel, M; Macintyre, EA; Stamatopoulos, K; Trka, J; Langerak, AW; Gonzalez, D; Pott, C; Bruggemann, M; Darzentas, N, 2019: Quality control and quantification in IG/TR next-generation sequencing marker identification: protocols and bioinformatic functionalities by EuroClonality-NGS. LEUKEMIA 33(9), p. 2254 - 2265, doi: 10.1038/s41375-019-0499-4
• Bruggemann, M; Kotrova, M; Knecht, H; Bartram, J; Boudjogrha, M; Bystry, V; Fazio, G; Fronkova, E; Giraud, M; Grioni, A; Hancock, J; Herrmann, D; Jimenez, C; Krejci, A; Moppett, J; Reigl, T; Salson, M; Scheijen, B; Schwarz, M; Songia, S; Svaton, M; van Dongen, JJM; Villarese, P; Wakeman, S; Wright, G; Cazzaniga, G; Davi, F; Garcia-Sanz, R; Gonzalez, D; Groenen, PJTA; Hummel, M; Macintyre, EA; Stamatopoulos, K; Pott, C; Trka, J; Darzentas, N; Langerak, AW, 2019: Standardized next-generation sequencing of immunoglobulin and T-cell receptor gene recombinations for MRD marker identification in acute lymphoblastic leukaemia; a EuroClonality-NGS validation study. LEUKEMIA 33(9), p. 2241 - 2253, doi: 10.1038/s41375-019-0496-7
• Grioni, A; Fazio, G; Rigamonti, S; Bystry, V; Daniele, G; Dostalova, Z; Quadri, M; Saitta, C; Silvestri, D; Songia, S; Storlazzi, CT; Biondi, A; Darzentas, N; Cazzaniga, G, 2019: A Simple RNA Target Capture NGS Strategy for Fusion Genes Assessment in the Diagnostics of Pediatric B-cell Acute Lymphoblastic Leukemia. HEMASPHERE 3(3), doi: 10.1097/HS9.0000000000000250

2018

• Culen, M; Kosarova, Z; Jeziskova, I; Folta, A; Chovancova, J; Loja, T; Tom, N; Bystry, V; Janeckova, V; Dvorakova, D; Mayer, J; Racil, Z, 2018: The influence of mutational status and biological characteristics of acute myeloid leukemia on xenotransplantation outcomes in NOD SCID gamma mice. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY 144(7), p. 1239 - 1251, doi: 10.1007/s00432-018-2652-2
• Kubesova, B; Pavlova, S; Malcikova, J; Kabathova, J; Radova, L; Tom, N; Tichy, B; Plevova, K; Kantorova, B; Fiedorova, K; Slavikova, M; Bystry, V; Kissova, J; Gisslinger, B; Gisslinger, H; Penka, M; Mayer, J; Kralovics, R; Pospisilova, S; Doubek, M, 2018: Low-burden TP53 mutations in chronic phase of myeloproliferative neoplasms: association with age, hydroxyurea administration, disease type and JAK2 mutational status. LEUKEMIA 32(2), p. 450 - 461, doi: 10.1038/leu.2017.230
• Tom, N; Tom, O; Malcikova, J; Pavlova, S; Kubesova, B; Rausch, T; Kolarik, M; Benes, V; Bystry, V; Pospisilova, S, 2018: ToTem: a tool for variant calling pipeline optimization. BMC BIOINFORMATICS 19, doi: 10.1186/s12859-018-2227-x

2017

• Roy, A; Bystry, V; Bohn, G; Goudevenou, K; Reigl, T; Papaioannou, M; Krejci, A; O´Byrne, S; Chaidos, A; Grioni, A; Darzentas, N; Roberts, IAG; Karadimitris, A, 2017: High resolution IgH repertoire analysis reveals fetal liver as the likely origin of life-long, innate B lymphopoiesis in humans. CLINICAL IMMUNOLOGY 183, p. 8 - 16, doi: 10.1016/j.clim.2017.06.005
• Knecht, H; Kotrova, M; Reigl, T; Krejci, A; Herrmann, D; Schwarz, M; Bystry, V; Darzentas, N; Bruggemann, M, 2017: T-CELL RECEPTOR. REPERTOIRE CHARACTERISTICS IN RELAPSED/REFRACTORY B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA ON BLINATUMOMAB TREATMENT. HAEMATOLOGICA 102, p. 329 - 330
• Pal, K; Bystry, V; Reigl, T; Demko, M; Krejci, A; Touloumenidou, T; Stalika, E; Tichy, B; Ghia, P; Stamatopoulos, K; Pospisilova, S; Malcikova, J; Darzentas, N, 2017: GLASS: assisted and standardized assessment of gene variations from Sanger sequence trace data. BIOINFORMATICS 33(23), p. 3802 - 3804, doi: 10.1093/bioinformatics/btx423
• Sellner, L; Bruggemann, M; Schlitt, M; Knecht, H; Herrmann, D; Reigl, T; Krejci, A; Bystry, V; Darzentas, N; Rieger, M; Dietrich, S; Luft, T; Ho, AD; Kneba, M; Dreger, P, 2017: GvL effects in T-prolymphocytic leukemia: evidence from MRD kinetics and TCR repertoire analyses. BONE MARROW TRANSPLANTATION 52(4), p. 544 - 551, doi: 10.1038/bmt.2016.305
• Bystry, V.; Reigl, T; Krejci, A; Demko, M; Hanakova, B; Grioni, A; Knecht, H; Schlitt, M.; Dreger, P; Sellner, L;Herrmann, D; Pingeon, M; Boudjoghra, M; Rijntjes, J; Pott, C; Langerak, A W; Groenen P. J; Davi, F; Brüggemann, M; Darzentas, N, 2017: ARResT/Interrogate: an interactive immunoprofiler for IG/TR NGS data. 33(3), p. 435 - 437

2016

• Bousios, A; Diez, CM; Takuno, S; Bystry, V; Darzentas, N; Gaut, BS, 2016: A role for palindromic structures in the cis-region of maize Sirevirus LTRs in transposable element evolution and host epigenetic response. GENOME RESEARCH 26(2), p. 226 - 237, doi: 10.1101/gr.193763.115
• Sellner, L; Bruggemann, M; Schlitt, M; Knecht, H; Herrmann, D; Reigl, T; Krejci, A; Bystry, V; Darzentas, N; Rieger, M; Dietrich, S; Zenz, T; Ho, AD; Kneba, M; Dreger, P, 2016: Graft-versus-leukemia effects in T-prolymphocytic leukemia: evidence from MRD kinetics and TCR repertoire analyses. BONE MARROW TRANSPLANTATION 51, p. S68 - S69
• Sellner, L; Bruggemann, M; Schlitt, M; Knecht, H; Herrmann, D; Reigl, T; Krejci, A; Bystry, V; Darzentas, N; Rieger, M; Dietrich, S; Zenz, T; Ho, AD; Kneba, M; Dreger, P, 2016: Graft-versus-leukemia effects in T-prolymphocytic leukemia: evidence from minimal residual disease kinetics and T cell receptor repertoire analyses. ONCOLOGY RESEARCH AND TREATMENT 39, p. 78 - 78
• Grioni, A; Fazio, G; Reigl, T; Rigamonti, S; Bystry, V; Songia, S; Biondi, A; Darzentas, N; Cazzaniga, G, 2016: A PLATFORM FOR DETECTION OF FUSION GENES IN ALL FROM TARGET CAPTURE NEXT- GENERATION SEQUENCING OF DNA AND RNA. HAEMATOLOGICA 101, p. 26 - 27

2015

• Bystry, V; Agathangelidis, A; Bikos, V; Sutton, LA; Baliakas, P; Hadzidimitriou, A; Stamatopoulos, K; Darzentas, N, 2015: ARResT/AssignSubsets: a novel application for robust subclassification of chronic lymphocytic leukemia based on B cell receptor IG stereotypy. BIOINFORMATICS 31(23), p. 3844 - 3846, doi: 10.1093/bioinformatics/btv456
• Kotrova, M; Knecht, H; Bartram, J; Bystry, V; Cazzaniga, G; Fazio, G; Ferrero, S; Genuardi, E; Garcia-Sanz, R; Grioni, A; Hancock, J; Jiminez, C; Ladetto, M; Moppett, J; Songia, S; Herrmann, D; Pott, C; Langerak, AW; Darzentas, N; Trka, J; Fronkova, E; Bruggemann, M, 2015: Library Preparation Is the Major Factor Affecting Differences in Results of Immunoglobulin Gene Rearrangements Detection on Two Major Next-Generation Sequencing Platforms. BLOOD 126(23)
• Sellner, L; Dreger, P; Schlitt, M; Knecht, H; Herrmann, D; Reigl, T; Krejci, A; Bystry, V; Darzentas, N; Rieger, M; Dietrich, S; Zenz, T; Ho, AD; Kneba, M; Brueggemann, M, 2015: T-Prolymphocytic Leukemia Is Sensitive to Polyclonal T Cell-Derived Graft-Versus-Leukemia Effects: Evidence from Minimal Residual Disease Kinetics and TCR Repertoire Diversity Analyses. BLOOD 126(23)
• Bruggermann, M; Knecht, H; Bartram, J; Bystry, V; Cazzaniga, G; Fazio, G; Ferrero, S; Fronkova, E; Garcia-Sanz, R; Grioni, A; Hancock, J; Jiminez, C; Kotrova, M; Ladetto, M; Moppett, J; Songia, S; Trka, J; Langerak, AW; Darzentas, N; Herrmann, D; Pott, C, 2015: INTERNATIONAL MULTI-LABORATORY NEXT-GENERATION SEQUENCING FOR MRD ANALYSIS IN ALL. A PILOT STUDY BY THE EUROCLONALITY-NGS CONSORTIUM. HAEMATOLOGICA 100, p. 31 - 31
• Agathangelidis, A; Bystry, V; Hadzidimitriou, A; Sutton, LA; Minga, E; Kienle, D; Davis, Z; Yan, XJ; Shanafelt, T; Boudjogra, M; Plevova, K; Gounari, M; Xochelli, A; Navarro, A; Chatzouli, M; Pedersen, LB; Baliakas, P; Scarfo, L; Rossi, D; Veronese, S; Facco, M; Bikos, V; Karan-Djurasevic, T; Pavlovic, S; Mansouri, L; Poiron, C; Chu, CC; Stalika, E; Giudicelli, V; Panagiotidis, P; Sudarikov, A; Anagnostopoulos, A; Trentin, L; Catherwood, M; Montillo, M; Gaidano, G; Campo, E; Geisler, CH; Langerak, AW; Pospisilova, S; Lefranc, MP; Chiorazzi, N; Oscier, D; Jelinek, DF; Stilgenbauer, S; Belessi, C; Davi, F; Rosenquist, R; Ghia, P; Darzentas, N; Stamatopoulos, K, 2015: HIGHER-ORDER IMMUNOGLOBULIN SEQUENCE RELATIONS FOR MAJOR SUBSETS OF CHRONIC LYMPHOCYTIC LEUKEMIA: UNIQUENESS VERSUS EQUIVALENCE. HAEMATOLOGICA 100, p. 47 - 48

• Vývoj aplikace na integraci genomických a transcriptomických dat získaných sekvenováním nové generace pro klinické účely, , 2020 - 2022
• Expression and function of activation-induced cytidine deaminase splice variants in normal B cell physiology and chronic lymphocytic leukemia (3SGA5792), Jihomoravský kraj, 2013 - 2016
• Analysis of EGFR signalling and microRNA expression profiles in prediction of response to anti-EGFR (NT/13860), Ministry of Health - Ministry of Health´s Departmental Research and Development Programme III (2010-2015), 2012 - 2015
• MicroRNA analysis in glioblastoma stem cells: prediction of therapy response and identification of new therapeutic targets in glioblastoma patients (NT/13514), Ministry of Health - Ministry of Health´s Departmental Research and Development Programme III (2010-2015), 2012 - 2015
• Complex characterization of molecular genetic changes in glioblastoma multiforme and its relapses, and evaluation of their possible significance in oncologic therapy and therapy effect (NT/13581), Ministry of Health - Ministry of Health´s Departmental Research and Development Programme III (2010-2015), 2012 - 2015
• Functional and structural changes of microRNAs in lymphoproliferative malignancies and their impact on prognosis and prediction of therapy response (NT11218), Ministry of Health - Ministry of Health´s Departmental Research and Development Programme III (2010-2015), 2010 - 2015
• Studium mikroRNA a genů asociovaných s procesem epiteliálně-mezenchymální tranzice jako potenciálních markerů pro predikci rizika a časný záchyt metastazování u pacientů s renálním karcinomem (NT13547-4/2012), Ministry of Health of the CR, 2012 - 2015
• Development of diagnostic panel of circulating microRNAs for non-invasive early diagnostics and follow-up of colorectal cancer patients (NT/13549), Ministry of Health - Ministry of Health´s Departmental Research and Development Programme III (2010-2015), 2012 - 2015
• NGS-PTL - Next Generation Sequencing platform for targeted Personalized Therapy of Leukemia (306242), Evropská unie, 2012 - 2015
• Development of microRNA diagnostic panel for identification Barret esophagus patients at high-risk of progression to adenocarcinoma (NT13585), Ministry of Health - Ministry of Health´s Departmental Research and Development Programme III (2010-2015), 2012 - 2014
• SuPReMMe - Podpora profesního růstu a mezinárodní integrace výzkumných týmů v oblasti molekulární medicíny (CZ.1.07/2.3.00/20.0045), Ministerstvo školství, mládeže a tělovýchovy ČR, 2011 - 2014
• Real-time PCR soupravy pro diagnostiku v onkologii (FR-TI2/254), Ministerstvo průmyslu a obchodu ČR, 2010 - 2013
• Functional and molecular characteristics of cancer and normal stem cells - identification of targets for novel therapeutics and therapeutic strategies (MSM0021622430), Ministerstvo školství, mládeže a tělovýchovy ČR, 2007 - 2013
• Identification and functional characterization of microRNAs with predictive significance in patients with glioblastoma (NT/11214), Ministry of Health - Ministry of Health´s Departmental Research and Development Programme III (2010-2015), 2010 - 2013
• Involvement of nuclear HMGB proteins in sensitizing of human cells to anticancer drugs inhibiting DNA topoizomerases (GAP301/10/0590), Czech Science Foundation - Standard Grants, 2010 - 2012
• Analysis of changes in genome and its expression in chronic lymphocytic leukemia patients during the disease development (NS10439), Ministry of Health - Departmental Programme of Research and Development (2008-2011), 2009 - 2011